Kenvue rises after quarterly results beat
Shares of Tylenol maker Kenvue KVUE.N rise 4.2% to $24.08 premarket
KVUE says it earned a profit of 24 cents per share vs analysts' estimates of 23 cents per share - data compiled by LSEG
Reports Q1 revenue of $3.74 billion vs estimates of $3.67 billion
KVUE expects 2025 profit to remain flat year-over-year, anticipating higher costs from President Trump's tariffs on U.S. imports
Co had previously forecast 2025 profit to be flat to 2% growth
Separately, company appoints Amit Banati as chief financial officer, effective May 12
Up to last close, stock has risen 8.2% YTD
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Recommended Articles
Featured Tools
Top News
SanDisk Surges 8% as Earnings Countdown Begins - Here's What Every Investor Needs to Know

Azure Growth 40%, AI Revenue 37 Billion: Why Did Microsoft Shares Fall Instead of Rise?

Nvidia Stock Prediction: Can NVDA Hit $1,000 by 2030?

Robinhood Slumps 8% After Earnings. Revenue and Profit Both Miss, Market Fears Coinbase May Follow Suit.

GOOGL Vs. MSFT: 2 Monster Stocks to Hold for the Next 5 Years

Tradingkey







